Does IFOSFAMIDE Cause Diffuse large b-cell lymphoma refractory? 154 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 154 reports of Diffuse large b-cell lymphoma refractory have been filed in association with IFOSFAMIDE (IFEX). This represents 0.9% of all adverse event reports for IFOSFAMIDE.
154
Reports of Diffuse large b-cell lymphoma refractory with IFOSFAMIDE
0.9%
of all IFOSFAMIDE reports
25
Deaths
9
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From IFOSFAMIDE?
Of the 154 reports, 25 (16.2%) resulted in death, 9 (5.8%) required hospitalization, and 4 (2.6%) were considered life-threatening.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IFOSFAMIDE. However, 154 reports have been filed with the FAERS database.
What Other Side Effects Does IFOSFAMIDE Cause?
Off label use (2,281)
Febrile neutropenia (2,225)
Disease progression (1,912)
Neutropenia (1,509)
Drug ineffective (1,331)
Thrombocytopenia (1,227)
Anaemia (1,067)
Product use in unapproved indication (890)
Pyrexia (752)
Sepsis (712)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which IFOSFAMIDE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
IFOSFAMIDE vs IGURATIMOD
IFOSFAMIDE vs ILOPERIDONE
IFOSFAMIDE vs ILOPROST
IFOSFAMIDE vs IMATINIB
IFOSFAMIDE vs IMBRUVICA